4.6 Editorial Material

Ethics in the authorship and publishing of scientific articles

期刊

INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 144, 期 1, 页码 1-2

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2010.07.030

关键词

Medical journals; Cardiology; Ethics; Plagiarism; Scientific misconduct; Fraud; Authorship; Retraction

向作者/读者索取更多资源

All authors to papers in the International Journal of Cardiology must adhere to the following principles: 1. That the corresponding author has the approval of all other listed authors for the submission and publication of all versions of the manuscript. 2. That all people who have a right to be recognised as authors have been included on the list of authors and everyone listed as an author has made an independent material contribution to the manuscript. 3. That the work submitted in the manuscript is original and has not been published elsewhere and is not presently under consideration of publication by any other journal other than in oral, poster or abstract format. 4. That the material in the manuscript has been acquired according to modern ethical standards and has been approved by the legally appropriate ethical committee. 5. That the article does not contain material copied from anyone else without their written permission. 6. That all material which derives from prior work, including from the same authors, is properly attributed to the prior publication by proper citation. 7. That the manuscript will be maintained on the servers of the Journal and held to be a valid publication by the Journal only as long as all statements in these principles remain true. 8. That if any of the statements above ceases to be true the authors have a duty to notify the Journal as soon as possible so that the manuscript can be withdrawn. (C) 2010 Published by Elsevier Ireland Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry

Agnieszka Kaplon-Cieslicka, Lina Benson, Ovidiu Chioncel, Maria G. Crespo-Leiro, Andrew J. S. Coats, Stefan D. Anker, Gerasimos Filippatos, Frank Ruschitzka, Camilla Hage, Jaroslaw Drozdz, Petar Seferovic, Giuseppe M. C. Rosano, Massimo Piepoli, Alexandre Mebazaa, Theresa McDonagh, Mitja Lainscak, Gianluigi Savarese, Roberto Ferrari, Aldo P. Maggioni, Lars H. Lund

Summary: This study provides a comprehensive characterization of acute heart failure with preserved, mildly reduced, and reduced ejection fraction. The results show differences in hospitalization reasons, characteristics, treatment, and post-discharge risks among the three types.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

Javed Butler, Stefan D. Anker, Lars H. Lund, Andrew J. S. Coats, Gerasimos Filippatos, Tariq Jamal Siddiqi, Tim Friede, Vincent Fabien, Mikhail Kosiborod, Marco Metra, Ileana L. Pina, Fausto Pinto, Patrick Rossignol, Peter van der Meer, Cecilia Bahit, Jan Belohlavek, Michael Boehm, Jasper J. Brugts, John G. F. Cleland, Justin Ezekowitz, Antoni Bayes-Genis, Israel Gotsman, Assen Goudev, Irakli Khintibidze, Joann Lindenfeld, Robert J. Mentz, Bela Merkely, Eliodoro Castro Montes, Wilfried Mullens, Jose C. Nicolau, Aleksandr Parkhomenko, Piotr Ponikowski, Petar M. Seferovic, Michele Senni, Evgeny Shlyakhto, Alain Cohen-Solal, Peter Szecsoedy, Klaus Jensen, Fabio Dorigotti, Matthew R. Weir, Bertram Pitt

Summary: The study found that patiromer can significantly lower serum potassium levels and enable specified target doses of RAASi in patients with heart failure and reduced ejection fraction, reducing the risk of hyperkalemia.

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced

Stefan D. Anker, Muhammad Shahzeb Khan, Javed Butler, Anne Pernille Ofstad, Barbara Peil, Egon Pfarr, Wolfram Doehner, Naveed Sattar, Andrew J. S. Coats, Gerasimos Filippatos, Joao Pedro Ferreira, Faiez Zannad, Stuart Pocock, Milton Packer

Summary: In this study, the relationship between baseline BMI, weight loss, and the effects of empagliflozin on heart failure patients with reduced ejection fraction (HFrEF) were analyzed. The study found that the benefits of empagliflozin were consistent across all BMI categories, and weight loss was associated with increased risk of all-cause mortality regardless of treatment group.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Respiratory System

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Marc Humbert, Gabor Kovacs, Marius M. Hoeper, Roberto Badagliacca, Rolf M. F. Berger, Margarita Brida, Jorn Carlsen, Andrew J. S. Coats, Pilar Escribano-Subias, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Meszaros, Blin Nagavci, Karen M. Olsson, Joanna Pepke-Zaba, Jennifer K. Quint, Goran Radegran, Gerald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean Luc Vachiery, Anton Vonk Noordegraaf, Marion Delcroix, Stephan Rosenkranz

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Geriatrics & Gerontology

Long-term indoor gunshot exposure of special police forces induces bronchitic reactions and elevated blood lead levels-The Berlin shooting range study

Christian Witt, Camilla Kienast, Georg Boelke, Christina Hoffmann, Robert Roehle, Olaf Bender, Dennis Nowak, Rudolf Tauber, Hanns-Christian Gunga, Peter Hoffmann, Andrew J. S. Coats, Uta Liebers

Summary: This study investigated the respiratory health and burden of toxic elements in police officers with long-term exposure to indoor gunshot emissions. The results showed that higher exposure was associated with more respiratory symptoms, impaired lung function, and higher blood lead levels. The findings suggest the need to reduce exposure to gunshot emissions to prevent symptom exacerbation and lung function deterioration.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)

Article Geriatrics & Gerontology

The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model

Luping Yuan, Jochen Springer, Sandra Palus, Silvia Busquets, Queralt Jove, Edson Alves de Lima Junior, Markus S. Anker, Stephan von Haehling, Natalia Alvarez Ladron, Oliver Millman, Annemijn Oosterlee, Agata Szymczyk, Francisco Javier Lopez-Soriano, Stefan D. Anker, Andrew J. S. Coats, Josep M. Argiles

Summary: Stereoisomers of oxprenolol, especially S-oxprenolol, have shown effectiveness in preclinical models of cancer cachexia. S-oxprenolol was superior to R-oxprenolol in terms of survival and weight loss reduction in the animal models tested. It also improved muscle function and had potential for human application in cancer cachexia.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)

Article Economics

Clinical and economic impact of ferric carboxymaltose treatment for iron deficiency in patients stabilized following acute heart failure: a multinational study

Phil McEwan, Piotr Ponikowski, Tinevimbo Shiri, Giuseppe M. C. Rosano, Andrew J. S. Coats, Fabio Dorigotti, Antonio Ramirez de Arellano, Ewa A. Jankowska

Summary: This study evaluates the financial implications of introducing ferric carboxymaltose (FCM) for treating acute heart failure patients in the UK, Switzerland, and Italy. The findings suggest that FCM could lead to cost savings in the healthcare systems of these countries.

JOURNAL OF MEDICAL ECONOMICS (2023)

Article Cardiac & Cardiovascular Systems

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

Gerasimos Filippatos, Stefan D. Anker, Phyllis August, Andrew J. S. Coats, James L. Januzzi, Boris Mankovsky, Peter Rossing, Luis M. Ruilope, Bertram Pitt, Pantelis Sarafidis, John R. Teerlink, Chris J. Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George Bakris, Rajiv Agarwal

Summary: This study investigated the causes of mortality in patients with chronic kidney disease and type 2 diabetes. The findings showed that Finerenone significantly reduced the risk of all-cause and cardiovascular mortality in T2D patients across different stages of CKD, and particularly in preventing cardiovascular-related deaths and sudden cardiac death.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry

Chris J. Kapelios, Lina Benson, Maria G. Crespo-Leiro, Stefan D. Anker, Andrew J. S. Coats, Ovidiu Chioncel, Gerasimos Filippatos, Mitja Lainscak, Theresa McDonagh, Alexandre Mebazaa, Marco Metra, Massimo F. Piepoli, Giuseppe M. C. Rosano, Frank Ruschitzka, Gianluigi Savarese, Petar M. Seferovic, Maurizio Volterrani, Aldo P. Maggioni, Lars H. Lund

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology

Finn Gustafsson, Kevin Damman, Sanem Nalbantgil, Linda W. W. Van Laake, Laurens F. Tops, Thomas Thum, Stamatis Adamopoulos, Michael Bonios, Andrew J. S. Coats, Maria G. Crespo-Leiro, Mandeep R. Mehra, Gerasimos Filippatos, Loreena Hill, Marco Metra, Ewa Jankowska, Nicolaas de Jonge, David Kaye, Marco Masetti, John Parissis, Davor Milicic, Petar Seferovic, Giuseppe Rosano, Tuvia Ben Gal

Summary: This article reviews the clinical consensus on the use of inotropic support in patients with advanced heart failure. Current guidelines recommend inotropic use only in cases of acute decompensated heart failure with organ malperfusion or shock. However, inotropic support may be justified in other cases of advanced heart failure without severe acute decompensation. The article examines the clinical evidence supporting the use of inotropes in these situations, including patients with persistent congestion, systemic hypoperfusion, or advanced heart failure requiring palliation, and those undergoing left ventricular assist device implantation or heart transplantation.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Correction Cardiac & Cardiovascular Systems

Corrigendum to: Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (vol 29, pg 275, 2022)

Massimo F. Piepoli, Marianna Adamo, Andrea Barison, Reinaldo B. Bestetti, Jan Biegus, Michael Bohm, Javed Butler, Jonathan Carapetis, Claudio Ceconi, Ovidiu Chioncel, Andrew Coats, Maria G. Crespo-Leiro, Giovanni de Simone, Heinz Drexel, Michele Emdin, Dimitros Farmakis, Martin Halle, Stephane Heymans, Tiny Jaarsma, Ewa Jankowska, Mitja Lainscak, Carolyn S. P. Lam, Maja-Lisa Lochen, Yuri Lopatin, Aldo Maggioni, Benedetta Matrone, Marco Metra, Katharine Noonan, Ileana Pina, Eva Prescott, Giuseppe Rosano, Petar M. Seferovic, Karen Sliwa, Simon Stewart, Alicia Uijl, Ilonca Vaartjes, Roel Vermeulen, W. M. Verschuren, Maurizio Volterrani, Stephan Von Haehling, Arno Hoes

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Correction Cardiac & Cardiovascular Systems

Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (vol 43, pg 2185, 2022)

Suleman Aktaa, Gorav Batra, John G. F. Cleland, Andrew Coats, Lars H. Lund, Theresa McDonagh, Giuseppe Rosano, Petar Seferovic, Peter Vasko, Lars Wallentin, Aldo P. Maggioni, Barbara Casadei, Chris P. Gale

EUROPEAN HEART JOURNAL (2023)

Correction Cardiac & Cardiovascular Systems

Heart Failure Association/European Society of Cardiology Atlas second edition: new insights into understanding the burden of heart failure (vol 43, pg 4973, 2022)

Petar M. Seferovic, Giuseppe M. C. Rosano, Panos Vardas, Ivan Milinkovic, Marija Polovina, Adam Timmis, Andrew J. S. Coats

EUROPEAN HEART JOURNAL (2023)

Correction Cardiac & Cardiovascular Systems

Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy (vol 23, pg 527, 2021)

Karen Sliwa, Peter van der Meer, Mark C. Petrie, Alexandra Frogoudaki, Mark R. Johnson, Denise Hilfiker-Kleiner, Righab Hamdan, Alice M. Jackson, Bassem Ibrahim, Amam Mbakwem, Carsten Tschope, Vera Regitz-Zagrosek, Elmir Omerovic, Jolien Roos-Hesselink, Michael Gatzoulis, Oktay Tutarel, Susanna Price, Stephane Heymans, Andrew J. S. Coats, Christian Mueller, Ovidiu Chioncel, Thomas Thum, Rudolf A. de Boer, Ewa Jankowska, Piotr Ponikowski, Alexander R. Lyon, Giuseppe Rosano, Petar M. Seferovic, Johann Bauersachs

EUROPEAN JOURNAL OF HEART FAILURE (2022)

暂无数据